Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 338 articles:
HTML format
Text format



Single Articles


    February 2018
  1. BAROCAS JA, Tasillo A, Eftekhari Yazdi G, Wang J, et al
    Population level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States.
    Clin Infect Dis. 2018 Feb 6. pii: 4840186. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. CHAMBERS LC, Khosropour CM, Katz DA, Dombrowski JC, et al
    Racial/ethnic disparities in the lifetime risk of Chlamydia trachomatis diagnosis and adverse reproductive health outcomes among women in King County, Washington.
    Clin Infect Dis. 2018 Feb 6. pii: 4840254. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. GRANT RM, Mannheimer S, Hughes JP, Hirsch-Moverman Y, et al
    Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study.
    Clin Infect Dis. 2018 Feb 6. pii: 4840078. doi: 10.1093/cid/cix1086.
    PubMed     Text format     Abstract available


  4. QI Q, Hua S, Clish CB, Scott JM, et al
    Plasma tryptophan-kynurenine metabolites are altered in HIV infection and associated with progression of carotid artery atherosclerosis.
    Clin Infect Dis. 2018 Feb 3. pii: 4837274. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. BROOKS KM, George JM, Pau AK, Rupert A, et al
    Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir with Once-Weekly Isoniazid and Rifapentine.
    Clin Infect Dis. 2018 Feb 3. pii: 4836314. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. GLIDDEN DV, Mulligan K, McMahan V, Anderson PL, et al
    Metabolic Effects of Pre-Exposure Prophylaxis with Co-Formulated Tenofovir Disoproxal Fumarate and Emtricitabine.
    Clin Infect Dis. 2018 Feb 3. pii: 4836821. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. DINH TH, Mushavi A, Shiraishi RW, Tippett Barr B, et al
    Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother-Infant Pairs During the Transition
    Clin Infect Dis. 2018;66:576-585.
    PubMed     Text format     Abstract available


    January 2018
  8. ANDERSON AM, Tyor WR, Mulligan MJ, Waldrop-Valverde D, et al
    HIV p24 antigen is quantifiable at low concentrations in human cerebrospinal fluid with digital ELISA and is associated with decreased neuropsychological performance.
    Clin Infect Dis. 2018 Jan 29. pii: 4828064. doi: 10.1093.
    PubMed     Text format     Abstract available



  9. Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs.
    Clin Infect Dis. 2018 Jan 25. pii: 4823847. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. KENYON C
    Risks of antimicrobial resistance in N. gonorrhoeae associated with intensive screening programs in PrEP programs.
    Clin Infect Dis. 2018 Jan 23. pii: 4821305. doi: 10.1093.
    PubMed     Text format    


  11. JENNESS SM, Weiss KM, Goodreau SM, Gift T, et al
    Moving Forward with Treatment of Gonorrhea for Users of HIV Preexposure Prophylaxis Given the Threat of Antimicrobial Resistance.
    Clin Infect Dis. 2018 Jan 23. pii: 4821306. doi: 10.1093.
    PubMed     Text format    


  12. HOSSEINIPOUR MC, Kang M, Krown SE, Bukuru A, et al
    As-Needed versus Immediate Etoposide Chemotherapy in Combination with Antiretroviral Therapy for Mild or Moderate AIDS-associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial.
    Clin Infect Dis. 2018 Jan 22. pii: 4819203. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. FERRETTI F, Bestetti A, Yiannoutsos CT, Musick BS, et al
    Diagnostic and prognostic value of JC virus DNA in plasma in Progressive Multifocal Leukoencephalopathy.
    Clin Infect Dis. 2018 Jan 15. pii: 4808594. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. HSU KK, Molotnikov LE, Roosevelt KA, Elder HR, et al
    Characteristics of Cases with Repeated Sexually Transmitted Infections, Massachusetts, 2014-2016.
    Clin Infect Dis. 2018 Jan 13. pii: 4805962. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. MARAIS S, Roos I, Mitha A, Mabusha SJ, et al
    Spinal tuberculosis: Clinicoradiological findings in 274 patients.
    Clin Infect Dis. 2018 Jan 11. pii: 4797620. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. MAHALE P, Engels EA, Coghill AE, Kahn AR, et al
    Cancer risk in older people living with human immunodeficiency virus infection in the United States.
    Clin Infect Dis. 2018 Jan 8. pii: 4793024. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. NACHEGA JB, Sam-Agudu NA, Mofenson LM, Schechter M, et al
    Achieving Viral Suppression in 90% of People Living with HIV on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities.
    Clin Infect Dis. 2018 Jan 8. pii: 4793055. doi: 10.1093.
    PubMed     Text format    


  18. BARDENHEIER BH, McNeil MM, Wodi AP, McNicholl JM, et al
    Reply to Burgner, et al.
    Clin Infect Dis. 2018;66:319.
    PubMed     Text format    


  19. MEHTA K, Im A, Rahman F, Wang H, et al
    Epidemiology and Outcomes of Hematopoietic Stem Cell Transplant in HIV (+) Patients from 1998 to 2012: A Nationwide Analysis.
    Clin Infect Dis. 2018 Jan 6. pii: 4792772. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. LACOURSE SM, Cranmer LM, Njuguna IN, Gatimu J, et al
    Urine TB lipoarabinomannan (LAM) predicts mortality in hospitalized HIV-infected children.
    Clin Infect Dis. 2018 Jan 6. pii: 4792803. doi: 10.1093.
    PubMed     Text format     Abstract available


  21. COLE JH, Caan MWA, Underwood J, De Francesco D, et al
    No evidence for accelerated ageing-related brain pathology in treated HIV: longitudinal neuroimaging results from the Comorbidity in Relation to AIDS (COBRA) project.
    Clin Infect Dis. 2018 Jan 4. pii: 4788363. doi: 10.1093/cid/cix1124.
    PubMed     Text format     Abstract available


    December 2017
  22. BRUST JCM, Shah NS, Mlisana K, Moodley P, et al
    Improved survival and cure rates with concurrent treatment for MDR-TB/HIV co-infection in South Africa.
    Clin Infect Dis. 2017 Dec 26. pii: 4774985. doi: 10.1093/cid/cix1125.
    PubMed     Text format     Abstract available


  23. TAIWO BO, Marconi VC, Berzins B, Moser CB, et al
    Dolutegravir plus lamivudine maintain HIV-1 suppression through week 48 in a pilot randomized trial.
    Clin Infect Dis. 2017 Dec 26. pii: 4775007. doi: 10.1093/cid/cix1131.
    PubMed     Text format     Abstract available


  24. TRAN T, Guardigni V, Pencina KM, Amato AA, et al
    Atypical Skeletal Muscle Profiles in HIV+ Asymptomatic Middle-Aged Adults.
    Clin Infect Dis. 2017 Dec 25. pii: 4774570. doi: 10.1093/cid/cix1121.
    PubMed     Text format     Abstract available


  25. LIN TC, Gianella S, Tenenbaum T, Little SJ, et al
    A Simple Symptom Score for Acute HIV Infection in a San Diego Community Based Screening Program.
    Clin Infect Dis. 2017 Dec 25. pii: 4774597. doi: 10.1093/cid/cix1130.
    PubMed     Text format     Abstract available


  26. ARIKAWA S, Rollins N, Jourdain G, Humphrey J, et al
    Contribution of maternal ART and breastfeeding to 24-month survival in HIV-exposed uninfected children: an individual pooled analysis of African and Asian studies.
    Clin Infect Dis. 2017 Dec 21. pii: 4768415. doi: 10.1093/cid/cix1102.
    PubMed     Text format     Abstract available


  27. UNAL G, Alessandri-Gradt E, Leoz M, Pavie J, et al
    HIV-1 group O infection in France: clinical features and immunovirological response to antiretrovirals.
    Clin Infect Dis. 2017 Dec 21. pii: 4768322. doi: 10.1093/cid/cix1087.
    PubMed     Text format     Abstract available


  28. HUA S, Vigano S, Tse S, Zhengyu O, et al
    Pegylated IFN-alpha-induced NK cell activation is associated with HIV-1 DNA decline in ART-treated HIV-1/HCV co-infected patients.
    Clin Infect Dis. 2017 Dec 20. pii: 4767848. doi: 10.1093/cid/cix1111.
    PubMed     Text format     Abstract available


  29. GREENE SA, McGrath CJ, Lehman DA, Marson KG, et al
    Increased Cervical HIV RNA Shedding Among HIV-Infected Women Randomized to Loop Electrosurgical Excision Procedure (LEEP) compared to Cryotherapy for Cervical Intraepithelial Neoplasia 2/3.
    Clin Infect Dis. 2017 Dec 20. pii: 4767844. doi: 10.1093/cid/cix1096.
    PubMed     Text format     Abstract available


  30. STOCKDALE AJ, Saunders MJ, Boyd MA, Bonnett LJ, et al
    Effectiveness of protease inhibitor/nucleos(t)ide reverse transcriptase inhibitor-based second-line antiretroviral therapy for the treatment of HIV-1 infection in sub-Saharan Africa: systematic review and meta-analysis.
    Clin Infect Dis. 2017 Dec 20. pii: 4767830. doi: 10.1093/cid/cix1108.
    PubMed     Text format     Abstract available


  31. YEGANEH N, Kerin T, Ank B, Watts H, et al
    HIV antiretroviral resistance and transmission in mother-infant pairs enrolled in a large perinatal study.
    Clin Infect Dis. 2017 Dec 19. pii: 4762480. doi: 10.1093/cid/cix1104.
    PubMed     Text format     Abstract available


  32. MADHI SA, Cutland CL, Downs S, Jones S, et al
    Burden of respiratory syncytial virus infection in South African HIV-infected and HIV-uninfected pregnant and post-partum women: A longitudinal cohort study.
    Clin Infect Dis. 2017 Dec 15. pii: 4749671. doi: 10.1093/cid/cix1088.
    PubMed     Text format     Abstract available


  33. TAIWO BO, Zheng L, Stefanescu A, Nyaku A, et al
    ACTG A5353: A pilot study of dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA < 500,000 copies/mL.
    Clin Infect Dis. 2017 Dec 14. pii: 4743559. doi: 10.1093/cid/cix1083.
    PubMed     Text format     Abstract available


  34. RAYMOND S, Nicot F, Pallier C, Bellecave P, et al
    Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen.
    Clin Infect Dis. 2017 Dec 13. pii: 4736156. doi: 10.1093/cid/cix1070.
    PubMed     Text format     Abstract available


  35. MOULIGNIER A, Savatovsky J, Assoumou L, Lescure FX, et al
    Silent Cerebral Small-Vessel Disease Twice as Prevalent in Middle-Aged Well-Controlled cART-Treated HIV-Infected Individuals Than HIV-Uninfected Individuals.
    Clin Infect Dis. 2017 Dec 13. pii: 4737216. doi: 10.1093/cid/cix1075.
    PubMed     Text format     Abstract available


  36. CROWELL TA, Colby DJ, Pinyakorn S, Fletcher JLK, et al
    Acute Retroviral Syndrome is Associated with High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments.
    Clin Infect Dis. 2017 Dec 7. pii: 4706268. doi: 10.1093/cid/cix1063.
    PubMed     Text format     Abstract available


  37. RICKLES M, Rebeiro PF, Sizemore L, Juarez P, et al
    Tennessee's In-State Vulnerability Assessment for a 'Rapid Dissemination of HIV or HCV Infection' Event Utilizing Data about the Opioid Epidemic.
    Clin Infect Dis. 2017 Dec 7. pii: 4706246. doi: 10.1093/cid/cix1079.
    PubMed     Text format     Abstract available


  38. MA Y, Dou Z, Guo W, Mao Y, et al
    The Human Immunodeficiency Virus Care Continuum in China: 1985-2015.
    Clin Infect Dis. 2017 Dec 5. pii: 4693542. doi: 10.1093.
    PubMed     Text format     Abstract available


  39. ROUET F, Nouhin J, Zheng DP, Roche B, et al
    Massive Iatrogenic Outbreak of Human Immunodeficiency Virus Type 1 in Rural Cambodia, 2014-2015.
    Clin Infect Dis. 2017 Dec 4. pii: 4689456. doi: 10.1093/cid/cix1071.
    PubMed     Text format     Abstract available


  40. NOVELLI S, Lecuroux C, Avettand-Fenoel V, Seng R, et al
    Long-term therapeutic impact of the timing of ART in patients diagnosed with primary HIV-1 infection.
    Clin Infect Dis. 2017 Dec 2. pii: 4683678. doi: 10.1093/cid/cix1068.
    PubMed     Text format     Abstract available


    November 2017
  41. BHATIA P, Temple J, Kantor M
    Not your garden-variety bacteremia: Gardnerella in an immunocompromised man.
    Clin Infect Dis. 2017 Nov 29. pii: 4675229. doi: 10.1093/cid/cix1054.
    PubMed     Text format     Abstract available


  42. BRANSON BM, Chavez PR, Hanscom B, Greene E, et al
    Expanding hospital HIV testing in the Bronx, New York and Washington, D.C.: Results from the HPTN 065 study.
    Clin Infect Dis. 2017 Nov 27. pii: 4668360. doi: 10.1093/cid/cix1053.
    PubMed     Text format     Abstract available


  43. VANDORMAEL A, Barnighausen T, Herbeck J, Tomita A, et al
    Longitudinal trends in the prevalence of detectable HIV viremia: Population-based evidence from rural KwaZulu-Natal, South Africa.
    Clin Infect Dis. 2017 Nov 25. pii: 4662847. doi: 10.1093.
    PubMed     Text format     Abstract available


  44. MOORE DJ, Jain S, Dube MP, Daar ES, et al
    Randomized Controlled Trial of Daily Text Messages To Support Adherence to PrEP In At-Risk for HIV Individuals: The TAPIR Study.
    Clin Infect Dis. 2017 Nov 24. pii: 4656156. doi: 10.1093/cid/cix1055.
    PubMed     Text format     Abstract available


  45. BOEREKAMPS A, Newsum AM, Smit C, Arends JE, et al
    High treatment uptake in HIV/HCV-coinfected patients after unrestricted access to direct-acting antivirals in the Netherlands.
    Clin Infect Dis. 2017 Nov 23. pii: 4654728. doi: 10.1093/cid/cix1004.
    PubMed     Text format     Abstract available


  46. ROCKSTROH JK
    Is HCV elimination in well-defined patient groups possible?
    Clin Infect Dis. 2017 Nov 23. pii: 4654730. doi: 10.1093/cid/cix1010.
    PubMed     Text format    


  47. BOEREKAMPS A, Van den Berk GE, Fanny LN, Leyten EM, et al
    Declining HCV incidence in Dutch HIV positive men who have sex with men after unrestricted access to HCV therapy.
    Clin Infect Dis. 2017 Nov 23. pii: 4654729. doi: 10.1093/cid/cix1007.
    PubMed     Text format     Abstract available


  48. JUMARE J, Ndembi N, El-Kamary SS, Magder L, et al
    Cognitive function among antiretroviral treatment-naive individuals infected with HIV-1 Subtype G versus CRF02_AG in Nigeria.
    Clin Infect Dis. 2017 Nov 22. pii: 4647334. doi: 10.1093/cid/cix1019.
    PubMed     Text format     Abstract available


  49. SMITH RX, Guha A, Vaida F, Paul RH, et al
    Prefrontal recruitment mitigates risk taking behavior in HIV infected young adults.
    Clin Infect Dis. 2017 Nov 21. pii: 4644866. doi: 10.1093/cid/cix1031.
    PubMed     Text format     Abstract available


  50. WONG C, Gange SJ, Moore RD, Justice AC, et al
    Multimorbidity Among Persons Living with HIV in the U.S.
    Clin Infect Dis. 2017 Nov 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  51. BEDIMO RJ, Adams-Huet B, Poindexter J, Brown G, et al
    The Differential Effects of HIV and HCV on Bone Micro-Architecture and Fracture risk.
    Clin Infect Dis. 2017 Nov 14. doi: 10.1093/cid/cix1011.
    PubMed     Text format     Abstract available


  52. VEIT O, Domingo C, Niedrig M, Staehelin C, et al
    Long-term immune response to yellow fever vaccination in HIV-infected individuals depends on HIV-RNA suppression status: Implications for vaccination schedule.
    Clin Infect Dis. 2017 Nov 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  53. MCDONALD CR, Conroy AL, Gamble JL, Papp E, et al
    Estradiol Levels Are Altered in Human Immunodeficiency Virus-Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy.
    Clin Infect Dis. 2017 Nov 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  54. MAHESWARAN H, Clarke A, MacPherson P, Kumwenda F, et al
    Cost-effectiveness of community-based HIV self-testing in Blantyre, Malawi.
    Clin Infect Dis. 2017 Nov 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  55. AOKI A, Sakagami T, Yoshizawa K, Shima K, et al
    Clinical significance of interferon-gamma neutralizing autoantibodies against disseminated nontuberculous mycobacterial disease.
    Clin Infect Dis. 2017 Nov 8. doi: 10.1093.
    PubMed     Text format     Abstract available


  56. GIANELLA S, Haw JS, Blumenthal J, Sullivan B, et al
    The Importance of HIV Research for Transgender and Gender Non-Binary Individuals.
    Clin Infect Dis. 2017 Nov 8. doi: 10.1093.
    PubMed     Text format     Abstract available


  57. GRIESEL R, Stewart A, van der Plas H, Sikhondze W, et al
    Optimizing Tuberculosis Diagnosis in HIV-Infected Inpatients Meeting the Criteria of Seriously Ill in the WHO Algorithm.
    Clin Infect Dis. 2017 Nov 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  58. SCOTT N, Stoove M, Kelly SL, Wilson DP, et al
    Achieving 90-90-90 HIV targets will not be enough to achieve the HIV incidence reduction target in Australia.
    Clin Infect Dis. 2017 Nov 1. doi: 10.1093.
    PubMed     Text format     Abstract available


  59. SCHEER S, Hsu L, Schwarcz S, Pipkin S, et al
    Trends in the San Francisco HIV Epidemic in the "Getting to Zero" Era.
    Clin Infect Dis. 2017 Nov 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2017
  60. BRUCE RD, Merlin J, Lum PJ, Ahmed E, et al
    2017 HIV Medicine Association of Infectious Diseases Society of America Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With Human Immunodeficiency Virus.
    Clin Infect Dis. 2017;65:1601-1606.
    PubMed     Text format     Abstract available


  61. DE LEDINGHEN V, Laforest C, Hezode C, Pol S, et al
    Retreatment with sofosbuvir plus grazoprevir/elbasvir plus ribavirin of patients with hepatitis C virus genotype 1 or 4 who previously failed a NS5A or NS3-containing regimen. ANRS HC34 REVENGE.
    Clin Infect Dis. 2017 Oct 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  62. BALAJI AB, An Q, Smith JC, Newcomb ME, et al
    High HIV incidence and prevalence and associated factors among adolescent sexual minority males, 3 cities, 2015.
    Clin Infect Dis. 2017 Oct 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  63. YAYA I, Costa M, Marcellin F, Miailhes P, et al
    Gender, alcohol use and fibrosis in HIV-HCV co-infected individuals.
    Clin Infect Dis. 2017 Oct 23. doi: 10.1093.
    PubMed     Text format    


  64. MURNANE PM, Strehlau R, Shiau S, Patel F, et al
    Reply to van de Wijer et. al.
    Clin Infect Dis. 2017 Oct 23. doi: 10.1093.
    PubMed     Text format    


  65. ZHAO Y, Wu Z, McGoogan JM, Shi CX, et al
    Immediate antiretroviral therapy decreases mortality among patients with high CD4 counts in China: a nationwide, retrospective cohort study.
    Clin Infect Dis. 2017 Oct 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  66. HUAMAN MA, Ticona E, Miranda G, Kryscio RJ, et al
    The Relationship between Latent Tuberculosis Infection and Acute Myocardial Infarction.
    Clin Infect Dis. 2017 Oct 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  67. PARR JB, Lodge EK, Holzmayer V, Pepin J, et al
    An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood Spots.
    Clin Infect Dis. 2017 Oct 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  68. OSMAN M, Lee K, Du Preez K, Dunbar R, et al
    Excellent Treatment Outcomes in Children Treated for Tuberculosis Under Routine Operational Conditions in Cape Town, South Africa.
    Clin Infect Dis. 2017;65:1444-1452.
    PubMed     Text format     Abstract available


  69. AKILIMALI NA, Chang CC, Muema DM, Reddy T, et al
    Plasma But Not Cerebrospinal Fluid Interleukin 7 and Interleukin 5 Levels Pre-Antiretroviral Therapy Commencement Predict Cryptococcosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Clin Infect Dis. 2017;65:1551-1559.
    PubMed     Text format     Abstract available


  70. WANG L, Min JE, Zang X, Sereda P, et al
    Characterizing Human Immunodeficiency Virus Antiretroviral Therapy Interruption and Resulting Disease Progression Using Population-Level Data in British Columbia, 1996-2015.
    Clin Infect Dis. 2017;65:1496-1503.
    PubMed     Text format     Abstract available


  71. HO A, Aston SJ, Jary H, Mitchell T, et al
    Impact of HIV on the burden and severity of influenza illness in Malawian adults: a prospective cohort and parallel case-control study.
    Clin Infect Dis. 2017 Oct 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  72. BARBEE LA, Soge OO, Katz DA, Dombrowski JC, et al
    Increases in Neisseria gonorrhoeae with Reduced Susceptibility to Azithromycin among Men who have sex with Men (MSM), in Seattle, King County, Washington: 2012 - 2016.
    Clin Infect Dis. 2017 Oct 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  73. KENYON C
    Increases in asymptomatic early syphilis may be due to increases in repeat syphilis and not enhanced screening.
    Clin Infect Dis. 2017 Oct 16. doi: 10.1093.
    PubMed     Text format    


  74. COOKSON ST, Maloney SA
    Keeping Up With a World in Motion: Screening Strategies for Migrating Populations.
    Clin Infect Dis. 2017;65:1410-1411.
    PubMed     Text format    


  75. ADU-GYAMFI CG, Snyman T, Hoffmann CJ, Martinson NA, et al
    Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients.
    Clin Infect Dis. 2017;65:1356-1358.
    PubMed     Text format     Abstract available


  76. MEHTA SR, Chaillon A, Gaines TL, Gonzalez-Zuniga PE, et al
    Impact of Public Safety Policies on HIV Transmission Dynamics in Tijuana, Mexico.
    Clin Infect Dis. 2017 Oct 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  77. SMIT M, van Zoest RA, Nichols BE, Vaartjes I, et al
    Cardiovascular disease prevention policy in HIV: recommendations from a modelling study.
    Clin Infect Dis. 2017 Oct 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  78. TAO G, Hoover KW, Nye MB, Peters PJ, et al
    Infrequent testing of women for rectal chlamydia and gonorrhea in the United States.
    Clin Infect Dis. 2017 Oct 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  79. WAKE RM, Britz E, Sriruttan C, Rukasha I, et al
    High Cryptococcal Antigen Titers in Blood are Predictive of Subclinical Cryptococcal Meningitis Among HIV-Infected Patients.
    Clin Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format     Abstract available


  80. BRAUN DL, Marzel A, Steffens D, Schreiber PW, et al
    High rates of subsequent asymptomatic STIs and risky sexual behavior in patients initially presenting with primary HIV-1 infection.
    Clin Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format     Abstract available


  81. GEORGE IA, Spec A, Powderly WG, Santos CAQ, et al
    Comparative Epidemiology and Outcomes of HIV, Non-HIV Non-Transplant and Organ Transplant Associated Cryptococcosis: A Population-Based Study.
    Clin Infect Dis. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  82. PASQUIER E, Kunda J, De Beaudrap P, Loyse A, et al
    Long term mortality and disability in Cryptococcal Meningitis: a systematic literature review.
    Clin Infect Dis. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2017
  83. COLLINS IJ
    Time to switch to second-line antiretroviral therapy in children with HIV in Europe and Thailand.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format    


  84. THAO LTP, Heemskerk AD, Geskus RB, Mai NTH, et al
    Prognostic models for 9 month mortality in tuberculous meningitis.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  85. DIONNE-ODOM J, Geisler WM, Aaron KJ, Waites KB, et al
    High Prevalence of Multidrug-Resistant Mycoplasma genitalium in HIV-infected Men who have Sex with Men in Alabama.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  86. NEMES E, Hesseling AC, Tameris M, Mauff K, et al
    Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin (BCG) for Infants of HIV Infected Mothers: A Phase 2 Randomized Controlled Trial.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  87. SALAZAR-AUSTIN N, Hoffmann J, Cohn S, Mashabela F, et al
    Poor Obstetric and Infant Outcomes in HIV-Infected Pregnant Women with Tuberculosis in South Africa: The Tshepiso Study.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  88. NOSYK B, Min JE, Krebs E, Zang X, et al
    The cost-effectiveness of HIV testing and treatment engagement initiatives in British Columbia, Canada: 2011-2013.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  89. MACIAS J, Mancebo M, Merino D, Tellez F, et al
    Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.
    Clin Infect Dis. 2017;65:1012-1019.
    PubMed     Text format     Abstract available


  90. TRICKEY A, May MT, Schommers P, Tate J, et al
    CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
    Clin Infect Dis. 2017;65:959-966.
    PubMed     Text format     Abstract available


  91. PIROTH L, Launay O, Miailhes P, Carrat F, et al
    Isolated anti-HBc serological profile: has the time come to vaccinate?
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format    


  92. BRUCE RD, Merlin J, Lum PJ, Ahmed E, et al
    2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV.
    Clin Infect Dis. 2017 Sep 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  93. HUGHES AJ, Scheer S
    Evidence of STD testing outside of primary HIV care for people living with HIV in San Francisco, California.
    Clin Infect Dis. 2017 Sep 13. doi: 10.1093.
    PubMed     Text format    


  94. DIRO E, Ritmeijer K, Boelaert M, Alves F, et al
    Long-term clinical outcomes in visceral leishmaniasis-HIV co-infected patients during and after pentamidine secondary prophylaxis in Ethiopia: a single-arm clinical trial Authors and affiliations.
    Clin Infect Dis. 2017 Sep 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  95. ASSOUMOU SA, Tasillo A, Leff JA, Schackman BR, et al
    The cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings.
    Clin Infect Dis. 2017 Sep 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  96. DAVIS AP, Stern J, Tantalo L, Sahi S, et al
    How well do neurologic symptoms identify individuals with neurosyphilis?
    Clin Infect Dis. 2017 Sep 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  97. VAN DUIN D, Lok JJ, Earley M, Cober E, et al
    Colistin vs. Ceftazidime-avibactam in the Treatment of Infections due to Carbapenem-Resistant Enterobacteriaceae.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  98. DESAI SR, Nair A, Rylance J, Mujuru H, et al
    HIV-Associated Chronic Lung Disease in Children and Adolescents in Zimbabwe: Chest Radiographic and High-Resolution Computed Tomography Findings.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  99. SIVRO A, McKinnon LR, Yende-Zuma N, Gengiah S, et al
    Plasma Cytokine Predictors of Tuberculosis Recurrence in Antiretroviral-Treated Human Immunodeficiency Virus-infected Individuals from Durban, South Africa.
    Clin Infect Dis. 2017;65:819-826.
    PubMed     Text format     Abstract available


    August 2017
  100. MODY A, Roy M, Sikombe K, Savory T, et al
    Improved Retention with Six Month Clinic Return Intervals for Stable HIV-Infected Patients in Zambia.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  101. BALOGUN KA, Lenis MG, Papp E, Loutfy M, et al
    Elevated levels of estradiol in HIV-positive pregnant women on protease inhibitor-based regimens.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  102. ESMAEILI A, Mirzazadeh A, Morris MD, Hajarizadeh B, et al
    The effect of female sex on hepatitis C incidence among people who inject drugs: results from the international multi-cohort InC3 Collaborative.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  103. KOSS CA, Hosek SG, Bacchetti P, Anderson PL, et al
    Comparison of Measures of Adherence to HIV Preexposure Prophylaxis among Adolescent and Young Men Who Have Sex with Men in the United States.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  104. HAVENS PL, Stephensen CB, Van Loan MD, Schuster GU, et al
    Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults with HIV Infection Being Treated with Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial.
    Clin Infect Dis. 2017 Aug 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  105. KOUAME GM, Boyd A, Moh R, Badje A, et al
    Higher mortality despite early ART in HIV and hepatitis B virus coinfected patients with high HBV replication.
    Clin Infect Dis. 2017 Aug 19. doi: 10.1093.
    PubMed     Text format     Abstract available


  106. WANG H, Wan Z, Xu R, Guan Y, et al
    A Novel Human Pegivirus HPgV-2 (HHpgV-1) is Tightly Associated with HCV Infection and HCV/HIV-1 Co-Infection.
    Clin Infect Dis. 2017 Aug 19. doi: 10.1093.
    PubMed     Text format     Abstract available


  107. PULIDO F, Ribera E, Lagarde M, Perez-Valero I, et al
    Dual therapy with darunavir and ritonavir plus lamivudine versus triple therapy with darunavir and ritonavir plus tenofovir disoproxil fumarate and emtricitabine or abacavir and lamivudine for maintenance of HIV-1 viral suppression: randomised, open l
    Clin Infect Dis. 2017 Aug 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  108. MORIN S, Bazarova N, Jacon P, Vella S, et al
    The manufacturers' perspective on WHO Prequalification of In Vitro Diagnostics.
    Clin Infect Dis. 2017 Aug 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  109. KELLY EM, Dodge JL, Bacchetti P, Sarkar M, et al
    Moderate Alcohol use is not Associated with Fibrosis Progression in HIV/HCV Co-Infected Women: A Prospective Cohort Study.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  110. LO RE V 3RD
    Is Moderate Alcohol Consumption Safe for HIV/Hepatitis C Virus-Coinfected Women?
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    PubMed     Text format    


  111. BYRNE DD, Tate JP, Forde KA, Lim JK, et al
    Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  112. PARASKEVIS D, Kostaki E, Nikolopoulos GK, Sypsa V, et al
    Molecular tracing of the geographical origin of HIV-1 infection and patterns of epidemic spread among migrants who inject drugs in Athens.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  113. ENGELS EA, Yanik EL, Wheeler W, Gill MJ, et al
    Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America.
    Clin Infect Dis. 2017;65:636-643.
    PubMed     Text format     Abstract available


  114. VAN DUIN D, Bonomo RA
    Reply to Macesic et al.
    Clin Infect Dis. 2017;65:703-704.
    PubMed     Text format    


  115. HAKRE S, Casimier RO, Danboise BA, Peel SA, et al
    Enhanced Sexually Transmitted Infection Screening for Mycoplasma genitalium in Human Immunodeficiency Virus -Infected US Air Force Personnel.
    Clin Infect Dis. 2017 Aug 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  116. JORDAN MR, Penazzato M, Cournil A, Vubil A, et al
    HIV drug resistance in African infants and young children newly diagnosed with HIV: a multicounty analysis.
    Clin Infect Dis. 2017 Aug 8. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2017
  117. MARCUS JL, Hurley LB, Nguyen DP, Silverberg MJ, et al
    Redefining HIV Preexposure Prophylaxis Failures.
    Clin Infect Dis. 2017 Jul 29. doi: 10.1093.
    PubMed     Text format    


  118. SALINAS JL, Armstrong LR, Silk BJ, Haddad MB, et al
    Factors Associated with All-Cause Mortality among Patients with Multidrug-Resistant Tuberculosis - United States, 1993-2013.
    Clin Infect Dis. 2017 Jul 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  119. ERLANDSON KM, Kitch D, Wester WC, Kalayjian RC, et al
    The Impact of Statin and ACE-inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults with HIV Infection.
    Clin Infect Dis. 2017 Jul 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  120. SARKAR M, Dodge JL, Greenblatt RM, Kuniholm MH, et al
    Reproductive Aging and Hepatic Fibrosis Progression in HIV/Hepatitis C Virus Co-Infected Women.
    Clin Infect Dis. 2017 Jul 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  121. FLORIDIA M, Ciccacci F, Andreotti M, Hassane A, et al
    Tuberculosis case finding with combined rapid point of care assays (Xpert(R) MTB/RIF and LAM) in HIV-positive individuals starting antiretroviral treatment in Mozambique.
    Clin Infect Dis. 2017 Jul 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  122. ABONGOMERA C, Diro E, Vogt F, Tsoumanis A, et al
    The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study.
    Clin Infect Dis. 2017 Jul 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  123. PASTOR L, Casellas A, Ruperez M, Carrillo J, et al
    Interferon-gamma-Inducible Protein 10 (IP-10) as a Screening Tool to Optimize Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings.
    Clin Infect Dis. 2017 Jul 19. doi: 10.1093.
    PubMed     Text format     Abstract available


  124. BEYENE T, Zewde AG, Balcha A, Hirpo B, et al
    High Dose Fluconazole Monotherapy is Inadequate for CSF Cryptococcal Antigen Positive HIV-infected Persons in an Ethiopian CrAg Screening Program.
    Clin Infect Dis. 2017 Jul 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  125. OLIVER SE, Cope AB, Rinsky JL, Williams C, et al
    Increases in Ocular Syphilis-North Carolina, 2014-2015.
    Clin Infect Dis. 2017 Jul 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  126. SERPA JA, Rueda AM, Somasunderam A, Utay NS, et al
    Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection.
    Clin Infect Dis. 2017 Jul 7. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2017
  127. KATZ MJ, Gurses AP, Tamma PD, Cosgrove SE, et al
    Implementing Antimicrobial Stewardship in Long-term Care Settings: An Integrative Review Using a Human Factors Approach.
    Clin Infect Dis. 2017 Jun 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  128. SMITH SE, Pratt R, Trieu L, Barry PM, et al
    Epidemiology of pediatric multidrug-resistant tuberculosis in the United States, 1993-2014.
    Clin Infect Dis. 2017 Jun 19. doi: 10.1093.
    PubMed     Text format     Abstract available


  129. HIGDON MM, Le T, O'Brien KL, Murdoch DR, et al
    Association of C-Reactive Protein With Bacterial and Respiratory Syncytial Virus-Associated Pneumonia Among Children Aged <5 Years in the PERCH Study.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  130. PARK DE, Baggett HC, Howie SRC, Shi Q, et al
    Colonization Density of the Upper Respiratory Tract as a Predictor of Pneumonia-Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  131. LOSINA E, Hyle EP, Borre ED, Linas BP, et al
    Projecting 10-yr, 20-yr and Lifetime Risks of Cardiovascular Disease in Persons Living with HIV in the US.
    Clin Infect Dis. 2017 Jun 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  132. KOULLIAS Y, Sax PE, Fields NF, Walensky RP, et al
    Should we be testing for baseline integrase resistance in patients newly diagnosed with HIV?
    Clin Infect Dis. 2017 Jun 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  133. MCCOLLUM ED, Ginsburg AS
    Outpatient Management of Children With World Health Organization Chest Indrawing Pneumonia: Implementation Risks and Proposed Solutions.
    Clin Infect Dis. 2017 Jun 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  134. SCHALKWIJK S, Colbers A, Konopnicki D, Gingelmaier A, et al
    Lowered rilpivirine exposure during third trimester of pregnancy in HIV-1-positive women.
    Clin Infect Dis. 2017 Jun 8. doi: 10.1093.
    PubMed     Text format     Abstract available


  135. NEL JS, Lippincott CK, Berhanu R, Spencer DC, et al
    Does disseminated nontuberculous mycobacterial disease cause false-positive Determine B-LAM lateral flow assay results? A retrospective review.
    Clin Infect Dis. 2017 Jun 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  136. PENAZZATO M, Gnanashanmugam D, Rojo P, Lallemant M, et al
    Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations.
    Clin Infect Dis. 2017;64:1597-1603.
    PubMed     Text format     Abstract available


    May 2017
  137. SANDUL AL, Nwana N, Holcombe JM, Lobato MN, et al
    High Rate of Treatment Completion in Program Settings with 12-Dose Weekly Isoniazid and Rifapentine (3HP) for Latent Mycobacterium tuberculosis Infection.
    Clin Infect Dis. 2017 May 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  138. JAO J, Kacanek D, Williams PL, Geffner ME, et al
    Birth Weight and Preterm Delivery Outcomes of Perinatally vs. non-Perinatally HIV-infected Pregnant Women in the U.S.: Results from the PHACS SMARTT Study and IMPAACT P1025 Protocol.
    Clin Infect Dis. 2017 May 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  139. FEARNHILL E, Gourlay A, Malyuta R, Simmons R, et al
    A Phylogenetic Analysis of HIV-1 Sequences in Kiev: Findings among Key Populations.
    Clin Infect Dis. 2017 May 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  140. BRINKLEY-RUBINSTEIN L, Rosen DL, Christopher P, Bazerman L, et al
    Long Acting Injectable Anti-Retroviral Therapy: An Opportunity to Improve HIV Treatment and Reduce HIV Transmission among Persons being Released from Prison Facilities.
    Clin Infect Dis. 2017 May 26. doi: 10.1093.
    PubMed     Text format    


  141. KUNIHOLM MH, Strickler HD, Anastos K, Prokunina-Olsson L, et al
    Relationship of Genotype for HLA B*57 and IFNL4 with Disease Progression in Female HIV Controllers.
    Clin Infect Dis. 2017 May 24. doi: 10.1093.
    PubMed     Text format    


  142. PRODGER JL, Lai J, Reynolds SJ, Keruly JC, et al
    Reduced Frequency of Cells Latently Infected with Replication-Competent HIV-1 in Virally Suppressed Individuals Living in Rakai, Uganda.
    Clin Infect Dis. 2017 May 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  143. AIBANA O, Franke MF, Huang CC, Galea JT, et al
    Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression.
    Clin Infect Dis. 2017 May 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  144. BOHLIUS J
    Comparison of Kaposi sarcoma risk in HIV-positive adults across five continents: a multiregional multicohort study.
    Clin Infect Dis. 2017 May 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  145. HO EL, Maxwell CL, Dunaway SB, Sahi SK, et al
    Neurosyphilis Increases HIV-associated Central Nervous System Inflammation but Does Not Explain Cognitive Impairment in HIV-infected Individuals with Syphilis.
    Clin Infect Dis. 2017 May 19. doi: 10.1093.
    PubMed     Text format     Abstract available


  146. KAWKITINARONG K, Suwanpimolkul G, Kateruttanakul P, Manosuthi W, et al
    Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  147. TENFORDE MW, Mokomane M, Leeme T, Patel RKK, et al
    Advanced HIV disease in Botswana following successful antiretroviral therapy rollout: Incidence of and temporal trends in cryptococcal meningitis.
    Clin Infect Dis. 2017 May 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  148. JENNESS SM, Weiss KM, Goodreau SM, Gift T, et al
    Incidence of Gonorrhea and Chlamydia Following HIV Preexposure Prophylaxis among Men Who Have Sex with Men: A Modeling Study.
    Clin Infect Dis. 2017 May 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  149. FOLARANMI TA, Kretz CB, Kamiya H, MacNeil JR, et al
    Increased Risk for Meningococcal Disease among Men who have Sex with Men in the United States, 2012-2015.
    Clin Infect Dis. 2017 May 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  150. COLE SR, Edwards JK, Hall HI, Brookhart MA, et al
    Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United States.
    Clin Infect Dis. 2017 May 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  151. BAZAN JA, Turner AN, Kirkcaldy RD, Retchless AC, et al
    Large Cluster of Neisseria Meningitidis Urethritis in Columbus, Ohio, 2015.
    Clin Infect Dis. 2017 May 8. doi: 10.1093.
    PubMed     Text format     Abstract available


  152. HARAUSZ EP, Leigh J, Garcia-Prats AJ, Furin J, et al
    Stability of Second-Line Tuberculosis Medications Mixed with Milk or Yogurt.
    Clin Infect Dis. 2017 May 6. doi: 10.1093.
    PubMed     Text format    


  153. SOCIAS ME, Nosova E, Kerr T, Hayashi K, et al
    Patterns of transmitted drug resistance and virological response to first-line antiretroviral treatment among HIV-positive people who use illicit drugs in a Canadian setting.
    Clin Infect Dis. 2017 May 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  154. BARDENHEIER BH, McNeil MM, Wodi AP, McNicholl J, et al
    Risk of non-targeted infectious disease hospitalizations among U.S. children following inactivated and live vaccines, 2005-2014.
    Clin Infect Dis. 2017 May 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  155. SEIFERT M, Georghiou SB, Garfein RS, Catanzaro D, et al
    Impact of fluoroquinolone use on mortality among a cohort of suspected drug-resistant tuberculosis patients.
    Clin Infect Dis. 2017 May 5. doi: 10.1093.
    PubMed     Text format     Abstract available


  156. WALKER NF, Wilkinson KA, Meintjes G, Tezera LB, et al
    Matrix Degradation in Human Immunodeficiency Virus Type 1-Associated Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Syndrome: A Prospective Observational Study.
    Clin Infect Dis. 2017 May 5. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  157. ROSENBERG ES, Hall EW, Sullivan PS, Sanchez TH, et al
    Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010.
    Clin Infect Dis. 2017 Apr 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  158. DIEPSTRA KL, Rhodes AG, Bono RS, Patel S, et al
    Comprehensive Ryan White Assistance and HIV Clinical Outcomes: Retention in Care and Viral Suppression in a Medicaid Non-Expansion State.
    Clin Infect Dis. 2017 Apr 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  159. LORENZ DR, Dutta A, Mukerji SS, Holman A, et al
    Marijuana use impacts midlife cardiovascular events in HIV-infected men.
    Clin Infect Dis. 2017 Apr 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  160. GUTIERREZ-VALENCIA A, Benmarzouk-Hidalgo OJ, Rivas-Jeremias I, Espinosa N, et al
    Viral kinetics in semen with different antiretroviral families in treatment-naive HIV-infected patients: a randomized trial.
    Clin Infect Dis. 2017 Apr 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  161. EATON JW, Johnson CC, Gregson S
    The cost of not re-testing: HIV misdiagnosis in the ART 'test-and-offer' era.
    Clin Infect Dis. 2017 Apr 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  162. LAZAR R, Kersanske L, Xia Q, Daskalakis D, et al
    Hospitalization rates among people with HIV/AIDS in New York City, 2013.
    Clin Infect Dis. 2017 Apr 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  163. DAVIS NL, Wiener J, Juliano JJ, Adair L, et al
    Co-trimoxazole prophylaxis, asymptomatic malaria parasitemia, and infectious morbidity in HIV-exposed uninfected infants in Malawi: The BAN study.
    Clin Infect Dis. 2017 Apr 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  164. MURNANE PM, Strehlau R, Shiau S, Patel F, et al
    Switching to efavirenz versus remaining on ritonavir-boosted lopinavir in HIV-infected children exposed to nevirapine: long-term outcomes of a randomized trial.
    Clin Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  165. EATON EF, Gravett RM, Tamhane AR, Mugavero MJ, et al
    Antiretroviral Therapy Initiation and Changes in Self-Reported Depression.
    Clin Infect Dis. 2017 Apr 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  166. CHOW EPF, Callander D, Fairley CK, Zhang L, et al
    Increased syphilis testing of men who have sex with men: greater detection of asymptomatic early syphilis and relative reduction in secondary syphilis.
    Clin Infect Dis. 2017 Apr 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  167. GUARALDI G, Rockwood K
    Geriatric-HIV medicine is born.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    PubMed     Text format    


  168. UNDERWOOD J, Cole JH, Caan M, De Francesco D, et al
    Grey and white matter abnormalities in treated HIV-disease and their relationship to cognitive function.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  169. WALENSKY RP, Del Rio C, Armstrong WS
    Charting the Future of Infectious Disease: Anticipating and Addressing the Supply and Demand Mismatch.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    PubMed     Text format    


  170. SINGH HK, Del Carmen T, Freeman R, Glesby MJ, et al
    From One Syndrome to Many: Incorporating Geriatric Consultation into HIV Care.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  171. ADAORA A A, Cole SR, Eron JJ
    US Black Women and HIV Prevention: Time for New Approaches to Clinical Trials.
    Clin Infect Dis. 2017 Apr 5. doi: 10.1093.
    PubMed     Text format     Abstract available


  172. QIN Q, Guo W, Tang W, Mahapatra T, et al
    Spatial Analysis of the Human Immunodeficiency Virus Epidemic among Men Who Have Sex with Men in China, 2006-2015.
    Clin Infect Dis. 2017;64:956-963.
    PubMed     Text format     Abstract available


  173. MORRIS MD, Shiboski S, Bruneau J, Hahn JA, et al
    Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration.
    Clin Infect Dis. 2017;64:860-869.
    PubMed     Text format     Abstract available


  174. SUNGKANUPARPH S, Savetamornkul C, Pattanapongpaiboon W
    Primary Prophylaxis for Cryptococcosis With Fluconazole in Human Immunodeficiency Virus-Infected Patients With CD4 T-Cell Counts <100 Cells/microL and Receiving Antiretroviral Therapy.
    Clin Infect Dis. 2017;64:967-970.
    PubMed     Text format     Abstract available


  175. BROGER T, Basu Roy R, Filomena A, Greef CH, et al
    Diagnostic Performance of Tuberculosis-Specific IgG Antibody Profiles in Patients with Presumptive Tuberculosis from Two Continents.
    Clin Infect Dis. 2017;64:947-955.
    PubMed     Text format     Abstract available


  176. NOSKA AJ, Belperio PS, Loomis TP, O'Toole TP, et al
    Prevalence of HIV, HCV and HBV among Homeless and Non-homeless United States Veterans.
    Clin Infect Dis. 2017 Apr 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  177. WYLES D, Brau N, Kottilil S, Daar ES, et al
    Sofosbuvir and Velpatasvir for the Treatment of HCV in Patients Coinfected with HIV-1: an Open-Label, Phase 3 Study.
    Clin Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  178. JOHS NA, Wu K, Tassiopoulos K, Koletar SL, et al
    Disability among Middle-Aged and Older Persons with HIV Infection.
    Clin Infect Dis. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  179. SOHN AH, Hazra R
    Old Problems for New Providers: Managing the Postpediatric HIV Generation.
    Clin Infect Dis. 2017 Mar 24. doi: 10.1093.
    PubMed     Text format    


  180. JANSSEN S, Schutz C, Ward A, Nemes E, et al
    Mortality in Severe HIV-TB Associates with Innate Immune Activation and Dysfunction of Monocytes.
    Clin Infect Dis. 2017 Mar 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  181. BECOFSKY K, Wing EJ, McCaffery J, Bodreau M, et al
    A Randomized, Controlled Trial of a Behavioral Weight Loss Program for HIV-Infected Patients.
    Clin Infect Dis. 2017 Mar 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  182. HWANG C, Schurmann D, Sobotha C, Boffito M, et al
    Antiviral Activity, Safety, and Exposure-Response relationships of GSK3532795, a Second-Generation HIV-1 Maturation Inhibitor, administered as Monotherapy or in Combination with Atazanavir+/-Ritonavir in a Phase 2a Randomized, Dose-Ranging, Controlled
    Clin Infect Dis. 2017 Mar 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  183. BUTT AA, Ren Y, Lo Re V 3rd, Taddei T, et al
    Comparing Child-Pugh, MELD and FIB-4 to Predict Clinical Outcomes in HCV-Infected Persons: Results from ERCHIVES.
    Clin Infect Dis. 2017 Mar 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  184. ADACHI K, Xu J, Ank B, Watts DH, et al
    Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection.
    Clin Infect Dis. 2017 Mar 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  185. MADHI SA, Nunes M, Weinberg A, Kuwanda L, et al
    Contribution of serology assays in the evaluation of influenza virus infection rates and vaccine efficacy in pregnant women: Report from randomized controlled trials.
    Clin Infect Dis. 2017 Mar 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  186. THOMAS M, Hopkins C, Duffy E, Lee D, et al
    Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir.
    Clin Infect Dis. 2017 Mar 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  187. CURLIN ME, Gvetadze R, Leelawiwat W, Martin M, et al
    Analysis of false-negative HIV rapid tests performed on oral fluid in three international clinical research studies.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  188. GOURLAY A, Noori T, Pharris A, Axelsson M, et al
    The HIV continuum of care in European Union countries in 2013: data and challenges.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  189. BERSHETYN A, Odeny TA, Lyamuya R, Nakiwogga-Muwanga A, et al
    The causal effect of tracing by peer health workers on return to clinic among patients who were lost to follow-up from antiretroviral therapy in eastern Africa: a randomized "natural experiment" arising from surveillance of lost patients.
    Clin Infect Dis. 2017 Mar 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  190. WHITE AC JR
    Treatment of Early Syphilis in HIV: What Do We Really Know?
    Clin Infect Dis. 2017;64:765-766.
    PubMed     Text format    


  191. COLLIER D, Iwuji C, Derache A, de Oliveira T, et al
    Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.
    Clin Infect Dis. 2017 Mar 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  192. HERRICK JA, Legrand F, Gounoue R, Nchinda G, et al
    Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection.
    Clin Infect Dis. 2017 Mar 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  193. KUGATHASAN R, Collier DA, Haddow LJ, El Bouzidi K, et al
    Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms.
    Clin Infect Dis. 2017 Mar 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  194. CEPEDA JA, Thomas DL, Astemborski J, Sulkowski MS, et al
    Increased mortality among persons with chronic hepatitis C with moderate or severe liver disease: a cohort study.
    Clin Infect Dis. 2017 Mar 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  195. HOFSTRA LM, Sanchez Rivas E, Nijhuis M, Bank LE, et al
    High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  196. CYKTOR JC, Mellors JW
    TLR Agonists: Can They Exact a Toll on HIV Persistence?
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format    


  197. VIBHOLM L, Schleimann MH, Hojen JF, Benfield T, et al
    Short-course TLR9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals with HIV infection.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  198. COLLINS IJ, Foster C, Tostevin A, Tookey P, et al
    Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  199. UPRETY P, Patel K, Karalius B, Ziemniak C, et al
    HIV-1 DNA Decay Dynamics with Early, Long-term Virologic Control of Perinatal Infection.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  200. PARKER RA, Rabideau DJ, Sax PE, Tierney C, et al
    The Impact of Medication Adherence on Virologic Failure in A5202, A Randomized, Partially-Blinded, Phase 3B Study.
    Clin Infect Dis. 2017 Mar 1. doi: 10.1093.
    PubMed     Text format     Abstract available


  201. NEGOESCU DM, Zhang Z, Bucher HC, Bendavid E, et al
    Differentiated HIV Rna Viral Load Monitoring in Resource Limited Settings: An Economic Analysis.
    Clin Infect Dis. 2017 Mar 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  202. NAGGIE S, Marks KM, Hughes M, Fierer DS, et al
    Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.
    Clin Infect Dis. 2017 Feb 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  203. LAKE JE, Stanley T, Apovian C, Bhasin S, et al
    Practical Review of Recognition and Management of Obesity and Lipohypertrophy in HIV Infection.
    Clin Infect Dis. 2017 Feb 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  204. BORGES AH, Hoy J, Florence E, Sedlacek D, et al
    Antiretrovirals, fractures and osteonecrosis in a large international HIV cohort.
    Clin Infect Dis. 2017 Feb 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  205. ELUL B, Saito S, Chung H, Hoos D, et al
    Attrition from HIV treatment programs in Africa: A longitudinal ecological analysis using data from 307,144 patients initiating antiretroviral therapy between 2005 and 2010.
    Clin Infect Dis. 2017 Feb 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  206. RAVIMOHAN S, Tamuhla N, Nfanyana K, Ni H, et al
    Elevated pre-ART CD39+CD8+ T-cell frequency is associated with early mortality in advanced HIV/TB.
    Clin Infect Dis. 2017 Feb 16. doi: 10.1093.
    PubMed     Text format    


  207. PETERS H, Francis K, Sconza R, Horn A, et al
    UK Mother-to-Child HIV Transmission Rates Continue to Decline: 2012-2014.
    Clin Infect Dis. 2017;64:527-528.
    PubMed     Text format    


  208. MORRIS SR, Zhao M, Smith DM, Vargas MV, et al
    Longitudinal Viral Dynamics in Semen During Early HIV Infection.
    Clin Infect Dis. 2017;64:428-434.
    PubMed     Text format    


  209. WONG C, Gange SJ, Buchacz K, Moore RD, et al
    First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000-2013.
    Clin Infect Dis. 2017;64:459-467.
    PubMed     Text format    


  210. LO RE V
    Extrahepatic Complications of Hepatitis C Virus Infection in HIV and the Impact of Successful Antiviral Treatment.
    Clin Infect Dis. 2017;64:498-500.
    PubMed     Text format    


  211. KOVARI H, Rauch A, Kouyos R, Rougemont M, et al
    Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2017;64:490-497.
    PubMed     Text format    


  212. ANDRADE R, Rodriguez-Barradas MC, Yasukawa K, Villarreal E, et al
    Single Dose Versus 3 Doses of Intramuscular Benzathine Penicillin for Early Syphilis in HIV: A Randomized Clinical Trial.
    Clin Infect Dis. 2017 Feb 14. doi: 10.1093.
    PubMed     Text format    


  213. FONJUNGO PN, Alemnji GA, Kebede Y, Opio A, et al
    Combatting Global Infectious Diseases: A Network Effect of Specimen Referral Systems.
    Clin Infect Dis. 2017 Feb 13. doi: 10.1093.
    PubMed     Text format    


  214. CLIFFORD GM, Tully S, Franceschi S
    Carcinogenicity of human papillomavirus types in HIV-positive women: A meta-analysis from HPV infection to cervical cancer.
    Clin Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    


  215. YOUNG J, Rossi C, Gill J, Walmsley S, et al
    Risk factors for hepatitis C virus reinfection after sustained virologic response in patients co-infected with HIV.
    Clin Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    


  216. BHATTACHARYA D, Belperio PS, Shahoumian TA, Loomis TP, et al
    Effectiveness of All-Oral Antiviral Regimens in 996 Genotype 1 HIV/HCV Coinfected Patients Treated in Routine Practice.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    PubMed     Text format    


  217. BURTON MJ, Naggie S
    Real World Effectiveness of DAA Therapies in HIV/HCV Co-Infection: 996 Veterans Can't Be Wrong.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    PubMed     Text format    


  218. BEGUELIN C, Friolet N, Moradpour D, Sahli R, et al
    Impact of tenofovir on hepatitis delta virus replication in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    PubMed     Text format    


  219. BAGHI HB, Aghazadeh M, Rashedi J, Poor BM, et al
    HIV/AIDS in Iran.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    PubMed     Text format    


  220. ANDREONI M, Teti E, Antinori A, Milazzoi L, et al
    Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients With HIV/HCV Coinfection: Results of an Italian Compassionate Use Program.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  221. DOMINGUEZ-MOLINA B, Tarancon-Diez L, Hua S, Abad-Molina C, et al
    HLA-B*57 and IFNL4-Related Polymorphisms Are Associated With Protection Against HIV-1 Disease Progression in Controllers.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  222. VEENHUIS RT, Astemborski J, Chattergoon MA, Greenwood P, et al
    Systemic Elevation of Proinflammatory Interleukin-18 in Human Immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) Coinfection Versus HIV or HCV Monoinfection.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  223. SPEC A, Olsen MA, Raval K, Powderly WG, et al
    Impact of Infectious Diseases Consultation on Mortality of Cryptococcal Infection in Patients Without HIV.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  224. FERRANDO-MARTINEZ S, De Pablo-Bernal RS, De Luna-Romero M, De Ory SJ, et al
    Thymic function failure is associated with HIV-disease progression.
    Clin Infect Dis. 2017 Feb 4. doi: 10.1093.
    PubMed     Text format    


  225. VINIKOOR MJ, Sinkala E, Chilengi R, Mulenga L, et al
    Impact of antiretroviral therapy on liver fibrosis among HIV-infected adults with and without HBV coinfection in Zambia.
    Clin Infect Dis. 2017 Feb 4. doi: 10.1093.
    PubMed     Text format    


  226. DUGAST AS, Arnold K, Lofano G, Moore S, et al
    Virus-driven inflammation is associated with the development of bNAbs in spontaneous controllers of HIV.
    Clin Infect Dis. 2017 Feb 3. doi: 10.1093.
    PubMed     Text format    


    January 2017
  227. PROANO A, Bravard MA, Lopez JW, Lee GO, et al
    Dynamics of Cough Frequency in Adults Undergoing Treatment for Pulmonary Tuberculosis.
    Clin Infect Dis. 2017 Jan 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  228. EL-MALLAWANY NK, Villiera J, Kamiyango W, Mhango J, et al
    Increasing Numbers of New Kaposi Sarcoma Diagnoses in HIV-Infected Children and Adolescents Despite the Wide Availability of Antiretroviral Therapy in Malawi.
    Clin Infect Dis. 2017 Jan 11. pii: ciw879. doi: 10.1093.
    PubMed     Text format    


  229. RIVERO-JUAREZ A, Frias M, Lopez-Lopez P, Risalde ML, et al
    Hepatitis E virus infection in anti-HEV IgG-carryinfing patients after successful HCV treatment: reactivation or reinfection?
    Clin Infect Dis. 2017 Jan 11. pii: cix004. doi: 10.1093.
    PubMed     Text format     Abstract available


  230. BANNAZADEH BAGHI H, Aghazadeh M, Rashedi J, Mahdavi Poor B, et al
    HIV/AIDS in Iran.
    Clin Infect Dis. 2017 Jan 11. pii: cix006. doi: 10.1093.
    PubMed     Text format    


    December 2016
  231. SORIA A, Alteri C, Scarlatti G, Bertoli A, et al
    Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report.
    Clin Infect Dis. 2016 Dec 28. pii: ciw851. doi: 10.1093.
    PubMed     Text format     Abstract available


  232. PINTYE J, Drake AL, Kinuthia J, Unger JA, et al
    A risk assessment tool for identifying pregnant and postpartum women who may benefit from pre-exposure prophylaxis (PrEP).
    Clin Infect Dis. 2016 Dec 28. pii: ciw850. doi: 10.1093.
    PubMed     Text format     Abstract available


  233. LIN A, Ong KJ, Hobbelen P, King E, et al
    Impact and cost-effectiveness of selective human papillomavirus vaccination of men who have sex with men.
    Clin Infect Dis. 2016 Dec 23. pii: ciw845. doi: 10.1093.
    PubMed     Text format     Abstract available


  234. PATEL EU, Kirkpatrick AR, Grabowski MK, Kigozi G, et al
    Penile Immune Activation and Risk of HIV Shedding: A Prospective Cohort Study.
    Clin Infect Dis. 2016 Dec 22. pii: ciw847. doi: 10.1093.
    PubMed     Text format     Abstract available


  235. MASSIMO A, Teti E, Antinori A, Milazzoi L, et al
    Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program.
    Clin Infect Dis. 2016 Dec 22. pii: ciw846. doi: 10.1093.
    PubMed     Text format     Abstract available


  236. DOMINGUEZ-MOLINA B, Tarancon-Diez L, Hua S, Abad-Molina C, et al
    HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  237. CRANSTON RD, Lama JR, Richardson BA, Carballo-Dieguez A, et al
    MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  238. LO RE V 3RD
    Extrahepatic Complications of Hepatitis C Virus Infection in HIV and the Impact of Successful Antiviral Treatment.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  239. KOVARI H, Rauch A, Kouyos R, Rougemont M, et al
    Hepatitis C infection and the risk of non-liver-related morbidity and mortality in HIV-positive persons in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  240. MATTSON CL, Bradley H, Beer L, Johnson C, et al
    Increased STD testing among sexually active persons receiving medical care for HIV infection in the United States, 2009 - 2013.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  241. ROJAS LJ, Salim M, Cober E, Richter SS, et al
    Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  242. WONG C, Gange SJ, Buchacz K, Moore RD, et al
    First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000-2013.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  243. SHIELS MS, Althoff KN, Pfeiffer RM, Achenbach CJ, et al
    HIV Infection, Immune Suppression and Age at Diagnosis of Non-AIDS-Defining Cancers.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  244. MAZUR NI, Bont L, Cohen AL, Cohen C, et al
    Severity of Respiratory Syncytial Virus Lower Respiratory Tract Infection with Viral Coinfection in HIV-uninfected Children.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  245. SPEC A, Olsen MA, Raval K, Powderly WG, et al
    Impact of Infectious Diseases Consultation on Mortality of Cryptococcal infection in Patients without HIV.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  246. MORRIS SR, Zhao M, Smith DR, Vargas MV, et al
    Longitudinal Viral Dynamics in Semen During Early HIV Infection.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  247. WALL EC, Mukaka M, Scarborough M, Ajdukiewicz KM, et al
    Prediction of outcome from adult bacterial meningitis in a high HIV seroprevalence, resource-poor setting using the Malawi Adult Meningitis Score (MAMS).
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  248. VEENHUIS RT, Astemborski J, Chattergoon MA, Greenwood P, et al
    Systemic Elevation of Proinflammatory Interleukin 18 in HIV/HCV Coinfection versus HIV or HCV Monoinfection.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  249. VINNARD C, King L, Munsiff S, Crossa A, et al
    The Long-Term Mortality of Tuberculosis Meningitis Patients in New York City: A Cohort Study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  250. MYER L, Dunning L, Lesosky M, Hsiao NY, et al
    Frequency of viremic episodes in HIV-infected women initiating antiretroviral therapy during pregnancy: a cohort study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  251. PETERS H, Francis K, Sconza R, Horn A, et al
    UK Mother to Child HIV Transmission Rates Continue to Decline: 2012-2014.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  252. BARGER-KAMATE B, Deloria Knoll M, Kagucia EW, Prosperi C, et al
    Pertussis-Associated Pneumonia in Infants and Children From Low- and Middle-Income Countries Participating in the PERCH Study.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


  253. NUNES MC, Downs S, Jones S, van Niekerk N, et al
    Bordetella pertussis Infection in South African HIV-Infected and HIV-Uninfected Mother-Infant Dyads: A Longitudinal Cohort Study.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


  254. SOOFIE N, Nunes MC, Kgagudi P, van Niekerk N, et al
    The Burden of Pertussis Hospitalization in HIV-Exposed and HIV-Unexposed South African Infants.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


  255. GILL CJ, Mwananyanda L, MacLeod W, Kwenda G, et al
    Incidence of Severe and Nonsevere Pertussis Among HIV-Exposed and -Unexposed Zambian Infants Through 14 Weeks of Age: Results From the Southern Africa Mother Infant Pertussis Study (SAMIPS), a Longitudinal Birth Cohort Study.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


    November 2016
  256. HAVENS PL, Stephensen CB, Van Loan MD, Schuster GU, et al
    Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.
    Clin Infect Dis. 2016 Nov 15. pii: ciw765. doi: 10.1093.
    PubMed     Text format     Abstract available


  257. MEIJIDE H, Mena A, Rodriguez-Osorio I, Castro-Iglesias A, et al
    Cancer Incidence in Persons Living With HIV.
    Clin Infect Dis. 2016 Nov 14. pii: ciw759. doi: 10.1093.
    PubMed     Text format    


  258. BADER J, Daumer M, Schoni-Affolter F, Boni J, et al
    Therapeutic immune recovery prevents emergence of CXCR4-tropic HIV-1.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  259. PANACKAL AA, Komori M, Kosa P, Khan O, et al
    Spinal Arachnoiditis as a Complication of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Adults.
    Clin Infect Dis. 2016 Nov 10. pii: ciw739. doi: 10.1093.
    PubMed     Text format     Abstract available


  260. GAISA M, Ita-Nagy F, Sigel K, Arens Y, et al
    High Rates of Anal High-Grade Squamous Intraepithelial Lesions in HIV-Infected Women Who Do Not Meet Screening Guidelines.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  261. FOSTER AL, Gaisa MM, Hijdra RM, Turner SS, et al
    Shedding of Hepatitis C Virus Into the Rectum of HIV-infected Men Who Have Sex With Men.
    Clin Infect Dis. 2016 Nov 9. pii: ciw740. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2016
  262. BHARTI AR, McCutchan A, Deutsch R, Smith DM, et al
    Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  263. PELOQUIN CA, Dorman SE, Vernon A, Battista Migliori G, et al
    Reply to Alffenaar et al.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  264. HUNT PW
    Very Early ART and Persistent Inflammation in Treated HIV.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  265. ROSADO-SANCHEZ I, Herrero-Fernandez I, Genebat M, Ruiz-Mateos E, et al
    Thymic Function Impacts the Peripheral CD4/CD8 Ratio of HIV-Infected Subjects.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  266. WU H, Mendoza MC, Huang YA, Hayes T, et al
    Uptake of HIV Preexposure Prophylaxis Among Commercially Insured Persons-United States, 2010-2014.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  267. RUSSELL K, Hills SL, Oster AM, Porse CC, et al
    Male-to-Female Sexual Transmission of Zika Virus-United States, January-April 2016.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  268. SAINZ T, Navarro ML
    HIV-Infected Youths: Transition in Spain Compared to the Netherlands.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  269. GOLDSCHMIDT RH
    Preexposure Prophylaxis in the United States: An Evolving HIV Prevention Opportunity.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  270. DELANEY KP, Hanson DL, Masciotra S, Ethridge SF, et al
    Time until emergence of HIV test reactivity following infection with HIV-1: Implications for interpreting test results and retesting after exposure.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  271. SERETI I, Krebs SJ, Phanuphak N, Fletcher JL, et al
    Initiation of antiretroviral therapy in early HIV infection reduces but does not abrogate chronic residual inflammation.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  272. BROWN L, Langelier C, Reid MJ, Rutishauser RL, et al
    Antimicrobial Resistance: A Call to Action!
    Clin Infect Dis. 2016.
    PubMed     Text format    


  273. NAHID P, Dorman SE, Alipanah N, Barry PM, et al
    Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
    Clin Infect Dis. 2016;63:853-67.
    PubMed     Text format     Abstract available


    September 2016
  274. COHEN M, Eshleman S, McCauley M, Chen Y, et al
    Antiretroviral therapy to prevent HIV acquisition: Limits of estimation from a population cohort.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  275. SELHORST P, Masson L, Ismail SD, Samsunder N, et al
    CErvicovaginal inflaMmation Facilitates Acquisition of less infectious HIV variants.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  276. LJUNGMAN P, Boeckh M, Hirsch HH, Josephson F, et al
    Definitions of CMV infection and disease in transplant patients for use in clinical trials.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  277. NAGGIE S, Holland D, Sulkowski MS, Thomas DL, et al
    HCV post-exposure prophylaxis in the healthcare worker: Why DAAs don't change a thing.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  278. BORDONI V, Sacchi A, Cimini E, Casetti R, et al
    Different Role of IL-7 and IL-18 in Affecting Lymphoid Hematopoietic Progenitor Cells and CD4 Homeostasis in Naive Primary and Chronic HIV-Infected patients.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  279. BROCK JB, Mena LA
    HIV Medicine Residency Training Correspondence.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  280. BOERMA RS, Boender TS, Bussink AP, Calis JC, et al
    Suboptimal viral suppression rates among HIV-infected children in low- and middle-income countries: a meta-analysis.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  281. CASTILLO-MANCILLA JR, Brown TT, Erlandson KM, Palella FJ Jr, et al
    Suboptimal cART Adherence is Associated with Higher Levels of Inflammation Despite HIV Suppression.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  282. THOMPSON-PAUL AM, Lichtenstein KA, Armon C, Palella FJ Jr, et al
    Cardiovascular disease risk prediction in the HIV Outpatient Study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  283. BORGES AH, Neuhaus J, Babiker AG, Henry K, et al
    Immediate antiretroviral therapy reduces risk of infection-related cancer during early HIV infection.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  284. SMITH DM, Nakazawa M, Freeman ML, Anderson CM, et al
    Asymptomatic CMV Replication during Early HIV-infection is Associated with Lower CD4/CD8 Ratio during HIV Treatment.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  285. JUDD A, Le Prevost M, Melvin D, Arenas-Pinto A, et al
    Cognitive function in young people with and without perinatal HIV in the AALPHI cohort in England: the role of non-HIV related factors.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available



  286. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  287. TINCATI C, Rainone V, Comi L, Pandolfo A, et al
    Cell-Mediated Immunity in HIV-Infected Males with HPV-Related Anal Dysplastic Lesions.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  288. JOHNSON G, Levison J, Malek J
    Should providers discuss breastfeeding with women living with HIV in high-income countries? An ethical analysis.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  289. TAO G, Hoover KW, Nye MB, Peters P, et al
    Rectal infection with Neisseria gonorrhoeae and Chlamydia trachomatis in males in the United States.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  290. DRABO EF, Hay JW, Vardavas R, Wagner ZR, et al
    A Cost-Effectiveness Analysis Of Pre-Exposure Prophylaxis For The Prevention Of HIV Among Los Angeles County Men Who Have Sex With Men.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  291. MAYER KH, Krakower DS
    Can We Afford to Control the HIV Epidemic with Antiretrovirals? Can We Afford Not to Do So?
    Clin Infect Dis. 2016.
    PubMed     Text format    


  292. GREBELY J, Mauss S, Brown A, Bronowicki JP, et al
    Efficacy and safety of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic HCV genotype 1 infection receiving opioid substitution therapy: Analysis of Phase 3 ION trials.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  293. POTARD V, Simon A, Lacombe JM, Parienti JJ, et al
    Switching to Raltegravir From a Virologically Effective Boosted Protease Inhibitor Regimen: A Comparative Effectiveness Analysis From the French Hospital Database on HIV (FHDH-ANRS CO4).
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  294. SALINAS JL, Rentsch C, Marconi VC, Tate J, et al
    Baseline, Time-updated, and Cumulative HIV Care Metrics for Predicting Acute Myocardial Infarction and All-Cause Mortality.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available



  295. Changing incidence and risk factors for Kaposi sarcoma by time since starting antiretroviral therapy: Collaborative analysis of 21 European cohort studies.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  296. INGILIZ P, Christensen S, Kimhofer T, Hueppe D, et al
    Sofosbuvir and Ledipasvir for 8 weeks for the treatment of chronic hepatitis C virus infection in HCV-mono-infected and HIV-HCV co-infected individuals - Results from the German hepatitis C cohort (GECCO-01).
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  297. NAHID P, Dorman SE, Alipanah N, Barry PM, et al
    Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  298. WITTKOP L
    Endstage liver disease in HIV infection: an avoidable burden?
    Clin Infect Dis. 2016.
    PubMed     Text format    


  299. KLEIN MB, Althoff KN, Jing Y, Lau B, et al
    Risk of endstage liver disease in HIV-viral hepatitis co-infected persons in North America from the early to modern antiretroviral therapy eras.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  300. ABRAVANEL F, Metivier S, Chauveau M, Peron JM, et al
    Transmission of HCV NS5A inhibitor-resistant variants among HIV-infected men who have sex with men.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  301. KAMSTRA R, Azoulay L, Steele R, Klein MB, et al
    Hospitalizations in immigrants and non-immigrants diagnosed with chronic hepatitis C infection in Quebec.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  302. BOETTIGER DC, Muktiarti D, Kurniati N, Truong KH, et al
    Early height and weight changes in children using cotrimoxazole prophylaxis with antiretroviral therapy.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  303. HAAS AD, Msukwa MT, Egger M, Tenthani L, et al
    Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's "Option B+" programme.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  304. MUKERJI SS, Locascio JJ, Misra V, Lorenz DR, et al
    Lipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV-Infected Men on Antiretroviral Therapy.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  305. HANNA DB, Ramaswamy C, Kaplan RC, Kizer JR, et al
    Trends in cardiovascular disease mortality among persons with HIV in New York City, 2001-2012.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  306. WEIJSENFELD AM, Smit C, Cohen S, Wit FW, et al
    Virological and Social outcomes of HIV-infected adolescents and young adults in the Netherlands before and after transition to adult care.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  307. BARLOW-MOSHA L, Angelidou K, Lindsey J, Archary M, et al
    Nevirapine- vs Lopinavir/Ritonavir-based Antiretroviral Therapy in HIV-infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available



  308. Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  309. WYLES DL, Sulkowski MS, Dieterich D
    Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.
    Clin Infect Dis. 2016;63 Suppl 1:S3-S11.
    PubMed     Text format     Abstract available


  310. MACBRAYNE CE, Kiser JJ
    Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV.
    Clin Infect Dis. 2016;63 Suppl 1:S12-23.
    PubMed     Text format     Abstract available


  311. WANGPATHARAWANIT P, Sungkanuparph S
    Switching Lopinavir/Ritonavir to Atazanavir/Ritonavir vs Adding Atorvastatin in HIV-Infected Patients Receiving Second-Line Antiretroviral Therapy With Hypercholesterolemia: A Randomized Controlled Trial.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  312. ROWAN SE, Rogers M, Bayer J, Smith L, et al
    Treatment of HCV in HIV coinfected individuals in real world clinical settings: results from two large HIV care clinics.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  313. AL-KINDI SG, Zidar DA, McComsey GA, Longenecker CT, et al
    Gender differences in statin prescription rate among patients living with HIV and HCV.
    Clin Infect Dis. 2016.
    PubMed     Text format    


    June 2016
  314. CREPAZ N, Tang T, Marks G, Mugavero MJ, et al
    Durable Viral Suppression and Transmission Risk Potential among Persons with Diagnosed HIV Infection: United States, 2012-2013.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  315. WEISER J, Beer L, West BT, Duke CC, et al
    Qualifications, Demographics, Satisfaction, and Future Capacity of the HIV Care Provider Workforce in the United States, 2013-2014.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  316. LYKINS J, Wang K, Wheeler K, Clouser F, et al
    Understanding Toxoplasmosis in the United States Through "Large Data" Analyses.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  317. WADA NI, Bream JH, Martinez-Maza O, Macatangay B, et al
    Inflammatory biomarkers predict mortality among HIV-suppressed men: a multisite prospective cohort study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  318. LOW AJ, Mburu G, Welton NJ, May MT, et al
    Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: a Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  319. BLOCH M, Kamminga J, Jayewardene A, Bailey M, et al
    A Screening Strategy for HIV-Associated Neurocognitive Disorders (HAND) that Accurately Identifies Patients Requiring Neurological Review.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  320. KEATING SM, Pilcher CD, Busch MP
    Timing is Everything - Shortcomings of Current HIV Diagnostics in the Early Treatment Era.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  321. DE SOUZA MS, Pinyakorn S, Akapirat S, Pattanachaiwit S, et al
    Initiation of Antiretroviral Therapy during Acute HIV-1 Infection leads to A High Rate of Non-Reactive HIV Serology.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  322. SOGNI P, Gilbert C, Lacombe K, Piroth L, et al
    All-oral DAA regimens in HIV-HCV coinfected cirrhotic patients are efficient and safe. Real-life results from the prospective ANRS CO13 - HEPAVIH cohort.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  323. ISA SE, Oche AO, Kang'ombe AR, Okopi JA, et al
    HIV and risk of type 2 diabetes in a large adult cohort in Jos, Nigeria.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  324. KASSAYE SG, Grossman Z, Balamane M, Johnston-White B, et al
    Transmitted HIV Drug Resistance High and Longstanding in Metropolitan Washington, D.C.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  325. GJAERDE LI, Shepherd L, Jablonowska E, Lazzarin A, et al
    Trends in incidences and risk factors for hepatocellular carcinoma and other liver events in HIV and hepatitis C virus co-infected individuals from 2001 to 2014: a multi-cohort study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  326. SCOTT C, Cavanaugh JS, Pratt R, Silk BJ, et al
    Human tuberculosis caused by Mycobacterium bovis in the United States, 2006-2013.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  327. HOOTS BE, Finlayson T, Nerlander L, Paz-Bailey G, et al
    Willingness to Take, Use of, and Indications for Pre-Exposure Prophylaxis among Men Who Have Sex with Men - 20 U.S. Cities, 2014.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  328. HEIDARY M, Nasiri MJ, Goudarzi M
    Why the HIV/AIDS prevalence was increased in Iran, despite the decreasing in the USA?
    Clin Infect Dis. 2016.
    PubMed     Text format    


    May 2016
  329. COOPER C, Naggie S, Saag M, Yang JC, et al
    Successful Retreatment of HCV in Patients Coinfected with HIV Who Failed 12 Weeks of Ledipasvir/Sofosbuvir.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  330. KELLY EM, Dodge JL, Sarkar M, French AL, et al
    Marijuana Use is not Associated with Progression to Advanced Liver Fibrosis in HIV/HCV Coinfected Women.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  331. GIORDANO TP, Cully J, Amico KR, Davila JA, et al
    A randomized trial to test a peer mentor intervention to improve outcomes in persons hospitalized with HIV infection.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  332. OLDENBURG CE, Barnighausen T, Tanser F, Iwuji CC, et al
    Antiretroviral therapy to prevent HIV acquisition in serodiscordant couples in a hyperendemic community in rural South Africa.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  333. MARQUINE MJ, Montoya JL, Umlauf A, Fazeli PL, et al
    The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  334. OFOTOKUN I, Titanji K, Lahiri CD, Vunnava A, et al
    A Single Dose Zoledronic Acid Infusion Prevents Antiretroviral Therapy-Induced Bone Loss in Treatment-naive HIV-infected Patients: a Phase IIb Trial.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  335. GLAUBIUS RL, Hood G, Penrose KJ, Parikh UM, et al
    Cost-Effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  336. MEHTA SR, Murrell B, Anderson CM, Kosakovsky Pond SL, et al
    Using HIV Sequence and Epidemiologic Data to Assess the Effect of Self-referral Testing for Acute HIV Infection on Incident Diagnoses in San Diego, California.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  337. REIDY W, Agarwal M, Chege D, Lamb M, et al
    Retention in Care Among HIV-Infected Patients on Antiretroviral Therapy and Among Those Not on Antiretroviral Therapy in Eastern Africa.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  338. TUCKER JD, Cao B, Li H, Tang S, et al
    Social Media Interventions to Promote HIV Testing.
    Clin Infect Dis. 2016.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: